Compare JANX & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JANX | TALK |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | 598 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 840.4M | 872.7M |
| IPO Year | 2021 | N/A |
| Metric | JANX | TALK |
|---|---|---|
| Price | $14.64 | $5.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $47.00 | $6.42 |
| AVG Volume (30 Days) | 845.1K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | N/A | $26.02 |
| Revenue Next Year | N/A | $21.24 |
| P/E Ratio | ★ N/A | $155.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $2.22 |
| 52 Week High | $35.34 | $5.23 |
| Indicator | JANX | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 59.43 | 48.93 |
| Support Level | $13.13 | $4.59 |
| Resistance Level | $15.49 | $5.23 |
| Average True Range (ATR) | 0.57 | 0.01 |
| MACD | 0.15 | -0.00 |
| Stochastic Oscillator | 84.78 | 16.67 |
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.